デフォルト表紙
市場調査レポート
商品コード
1234370

幹細胞バンキングの世界市場 (2023~2031年):成長・将来の展望・競合分析

Stem Cell Banking Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

出版日: | 発行: Acute Market Reports | ページ情報: 英文 115 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
幹細胞バンキングの世界市場 (2023~2031年):成長・将来の展望・競合分析
出版日: 2023年01月18日
発行: Acute Market Reports
ページ情報: 英文 115 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

新生児数の増加、生命を脅かす遺伝性疾患や慢性疾患の有病率の上昇などの要因が予測期間中の幹細胞バンキング市場の成長をサポートすると期待されています。さらに、幹細胞治療に対する人々の意識の高まり、可処分所得とヘルスケア支出の増加も、市場成長の一助となると期待されています。

当レポートでは、世界の幹細胞バンキングの市場を調査し、市場概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 幹細胞バンキング市場:競合分析

  • 主要ベンダーの市場ポジショニング
  • ベンダーの採用戦略
  • 主要な業界戦略
  • ティア分析

第4章 幹細胞バンキング市場:マクロ分析・市場力学

  • 市場規模の予測
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因・抑制要因の影響分析
  • シーソー分析

第5章 幹細胞バンキング市場:細胞タイプ別

  • 市場概要
  • 成長・収益分析
  • 市場の分類
    • 臍帯幹細胞
    • 成体幹細胞
    • 胚性幹細胞

第6章 幹細胞バンキング市場:バンクタイプ別

  • 市場概要
  • 成長・収益分析
  • 市場の分類
    • プライベートバンク
    • パブリックバンク
    • ハイブリッドバンク

第7章 幹細胞バンキング市場:用途別

  • 市場概要
  • 成長・収益分析
  • 市場の分類
    • サラセミア
    • 脳性麻痺
    • 糖尿病
    • 白血病
    • 自閉症
    • その他

第8章 北米の幹細胞バンキング市場

第9章 英国およびEUの幹細胞バンキング市場

第10章 アジア太平洋の幹細胞バンキング市場

第11章 ラテンアメリカの幹細胞バンキング市場

第12章 中東・アフリカの幹細胞バンキング市場

第13章 企業プロファイル

  • CBR Systems, Inc.
  • Cryo-Cell International, Inc.
  • Cordlife
  • Cryo-Save AG
  • Global Cord Blood Corporation
  • Americord Registry LLC
  • Smart Cells International Ltd.
  • Celgene Corporation
  • BrainStorm Cell Therapeutics
  • Regenerative Medical Services Pvt. Ltd.
  • American CryoStem Corporation
  • Cordlife Group Limited
  • Cryoholdco De LatinoAmerica
  • S.A.P.I. DE C.V.
  • StemCyte Cord Blood Bank
  • Covis Pharma.
  • CSG BIO
  • その他
図表

List of Tables

  • TABLE 1 Global Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 2 Global Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 3 Global Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 4 Global Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 5 North America Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 6 North America Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 7 North America Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 8 North America Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 9 U.S. Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 10 U.S. Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 11 U.S. Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 12 U.S. Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 13 Canada Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 14 Canada Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 15 Canada Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 16 Canada Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 17 Rest of North America Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 18 Rest of North America Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 19 Rest of North America Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 20 Rest of North America Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 21 UK and European Union Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 22 UK and European Union Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 23 UK and European Union Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 24 UK and European Union Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 25 UK Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 26 UK Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 27 UK Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 28 UK Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 29 Germany Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 30 Germany Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 31 Germany Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 32 Germany Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 33 Spain Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 34 Spain Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 35 Spain Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 36 Spain Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 37 Italy Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 38 Italy Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 39 Italy Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 40 Italy Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 41 France Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 42 France Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 43 France Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 44 France Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 45 Rest of Europe Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 46 Rest of Europe Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 47 Rest of Europe Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 48 Rest of Europe Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 49 Asia Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 50 Asia Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 51 Asia Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 52 Asia Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 53 China Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 54 China Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 55 China Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 56 China Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 57 Japan Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 58 Japan Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 59 Japan Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 60 Japan Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 61 India Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 62 India Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 63 India Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 64 India Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 65 Australia Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 66 Australia Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 67 Australia Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 68 Australia Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 69 South Korea Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 70 South Korea Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 71 South Korea Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 72 South Korea Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 73 Latin America Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 74 Latin America Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 75 Latin America Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 76 Latin America Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 77 Brazil Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 78 Brazil Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 79 Brazil Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 80 Brazil Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 81 Mexico Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 82 Mexico Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 83 Mexico Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 84 Mexico Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 85 Rest of Latin America Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 86 Rest of Latin America Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 87 Rest of Latin America Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 88 Rest of Latin America Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 89 Middle East and Africa Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 90 Middle East and Africa Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 91 Middle East and Africa Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 92 Middle East and Africa Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 93 GCC Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 94 GCC Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 95 GCC Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 96 GCC Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 97 Africa Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 98 Africa Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 99 Africa Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 100 Africa Stem Cell Banking Market By Application, 2020-2030, USD (Million)
  • TABLE 101 Rest of Middle East and Africa Stem Cell Banking Market By Cell Type, 2020-2030, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Stem Cell Banking Market By Umbilical cord stem cells, 2020-2030, USD (Million)
  • TABLE 103 Rest of Middle East and Africa Stem Cell Banking Market By Bank Type, 2020-2030, USD (Million)
  • TABLE 104 Rest of Middle East and Africa Stem Cell Banking Market By Application, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Stem Cell Banking Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Stem Cell Banking Market: Quality Assurance
  • FIG. 5 Global Stem Cell Banking Market, By Cell Type, 2021
  • FIG. 6 Global Stem Cell Banking Market, By Bank Type, 2021
  • FIG. 7 Global Stem Cell Banking Market, By Application, 2021
  • FIG. 8 Global Stem Cell Banking Market, By Geography, 2021
  • FIG. 9 Market Geographical Opportunity Matrix - Global Stem Cell Banking Market, 2021
  • FIG. 10 Market Positioning of Key Stem Cell Banking Market Players, 2021
  • FIG. 11 Global Stem Cell Banking Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 12 Global Stem Cell Banking Market, By Cell Type, 2021 Vs 2030, %
  • FIG. 13 Global Stem Cell Banking Market, By Bank Type, 2021 Vs 2030, %
  • FIG. 14 Global Stem Cell Banking Market, By Application, 2021 Vs 2030, %
  • FIG. 15 U.S. Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 16 Canada Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 17 Rest of North America Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 18 UK Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 19 Germany Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 20 Spain Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 21 Italy Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 22 France Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 23 Rest of Europe Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 24 China Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 25 Japan Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 26 India Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 27 Australia Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 28 South Korea Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 29 Rest of Asia Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 30 Brazil Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 31 Mexico Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 32 Rest of Latin America Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 33 GCC Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 34 Africa Stem Cell Banking Market (US$ Million), 2020 - 2030
  • FIG. 35 Rest of Middle East and Africa Stem Cell Banking Market (US$ Million), 2020 - 2030
目次
Product Code: 138131-01-23

Stem cells are a class of undifferentiated biological cells of a multicellular organism that have potential to produce indefinite cells of the same type, from which certain type of cells (replication) can be produced by differentiation in the body through early life and growth. There are three types of stem cells: umbilical cord stem cells, adult stem cells, and embryonic stem cells. The umbilical cord stem cells or multipotent stem cells are able to produce a small number of different cell types. Adult stem cells originate from adult tissue and redevelop into all the cell types of the organ from the origin. Embryonic stem cells or pluripotent stem cells are produced from the inner cell mass of a blastocyst (embryo). Stem cell banking procedure includes the collection and preservation of several types of stem cells. Once the collection is completed, these stem cells undergo processing and analysis procedures; viability and different genetic tests are performed on these stem cells and are cryopreserved & stored for future use. Stem cells are preserved under cryogenic conditions (freezing at a temperature below-150°C) for longer duration/years in order to retrieve and use them when required for therapeutic purposes such as to treat diseases which harm the blood & immune system and some metabolic disorders.

A surge in the number of newborns and rising prevalence of life-threatening genetic disorders & chronic diseases across the world are expected to support the market growth over the forecast period. Moreover, growing awareness among people about stem cell therapeutics coupled with increasing disposable income and healthcare spending are expected to assist in the market growth. On the contrary, high processing and storage costs are anticipated to hinder the market growth during the forecast period.

The umbilical cord stem cells segment is expected to spearhead the market from 2023 to 2031 owing to the higher adoption of umbilical cord stem cells to treat around 80 diseases. The private banks segment is anticipated to hold comparatively higher market share attributed to high revenue generation from greater service offering. The presence of major market players in the U.S. coupled with growing awareness among citizens about stem cell banking is poised to support the dominance of North America during the forecast period.

Key players identified in the global stem cell banking market include:

CBR Systems, Inc.

Cryo-Cell International, Inc.

Cordlife

Cryo-Save AG

Global Cord Blood Corporation

Americord Registry LLC

Smart Cells International Ltd.

Celgene Corporation

BrainStorm Cell Therapeutics

Regenerative Medical Services Pvt. Ltd.

American CryoStem Corporation

Cordlife Group Limited

Cryoholdco De LatinoAmerica

S.A.P.I. DE C.V.

StemCyte Cord Blood Bank

Covis Pharma

CSG BIO

Others

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Stem Cell Banking market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Stem Cell Banking market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Cell Type

Umbilical cord stem cells

Cord blood

Cord tissue

Placenta

Adult stem cells

Embryonic stem cells

Bank Type

Private Banks

Public Banks

Hybrid Banks

Application

Thalassemia

Cerebral Palsy

Diabetes

Leukemia

Autism

Others

Region Segment (2021-2031; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Stem Cell Banking market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Stem Cell Banking market?

Which is the largest regional market for Stem Cell Banking market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Stem Cell Banking market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Stem Cell Banking market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Stem Cell Banking Market
  • 2.2. Global Stem Cell Banking Market, By Cell Type, 2021 (US$ Million)
  • 2.3. Global Stem Cell Banking Market, By Bank Type, 2021 (US$ Million)
  • 2.4. Global Stem Cell Banking Market, By Application, 2021 (US$ Million)
  • 2.5. Global Stem Cell Banking Market, By Geography, 2021 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2021

3. Stem Cell Banking Market: Competitive Analysis

  • 3.1. Market Positioning of Key Stem Cell Banking Market Vendors
  • 3.2. Strategies Adopted by Stem Cell Banking Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Stem Cell Banking Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Stem Cell Banking Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Umbilical cord stem cells
      • 5.3.1.1. Cord blood
      • 5.3.1.2. Cord tissue
      • 5.3.1.3. Placenta
    • 5.3.2. Adult stem cells
    • 5.3.3. Embryonic stem cells

6. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 6.3. Market Segmentation
    • 6.3.1. Private Banks
    • 6.3.2. Public Banks
    • 6.3.3. Hybrid Banks

7. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 7.3. Market Segmentation
    • 7.3.1. Thalassemia
    • 7.3.2. Cerebral Palsy
    • 7.3.3. Diabetes
    • 7.3.4. Leukemia
    • 7.3.5. Autism
    • 7.3.6. Others

8. North America Stem Cell Banking Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
  • 8.3. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
  • 8.4. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
  • 8.5.Stem Cell Banking Market: By Region, 2020-2030, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 8.5.1.1.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 8.5.1.1.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 8.5.1.2.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 8.5.1.2.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 8.5.1.3.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 8.5.1.3.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)

9. UK and European Union Stem Cell Banking Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
  • 9.3. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
  • 9.4. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
  • 9.5.Stem Cell Banking Market: By Region, 2020-2030, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 9.5.1.1.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 9.5.1.1.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 9.5.1.2.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 9.5.1.2.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 9.5.1.3.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 9.5.1.3.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 9.5.1.4.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 9.5.1.4.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 9.5.1.5.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 9.5.1.5.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 9.5.1.6.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 9.5.1.6.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)

10. Asia Pacific Stem Cell Banking Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
  • 10.3. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
  • 10.4. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
  • 10.5.Stem Cell Banking Market: By Region, 2020-2030, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 10.5.1.1.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 10.5.1.1.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 10.5.1.2.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 10.5.1.2.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 10.5.1.3.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 10.5.1.3.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 10.5.1.4.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 10.5.1.4.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 10.5.1.5.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 10.5.1.5.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 10.5.1.6.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 10.5.1.6.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)

11. Latin America Stem Cell Banking Market, 2020-2030, USD (Million)

  • 11.1. Market Overview
  • 11.2. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
  • 11.3. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
  • 11.4. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
  • 11.5.Stem Cell Banking Market: By Region, 2020-2030, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 11.5.1.1.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 11.5.1.1.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 11.5.1.2.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 11.5.1.2.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 11.5.1.3.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 11.5.1.3.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)

12. Middle East and Africa Stem Cell Banking Market, 2020-2030, USD (Million)

  • 12.1. Market Overview
  • 12.2. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
  • 12.3. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
  • 12.4. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
  • 12.5.Stem Cell Banking Market: By Region, 2020-2030, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 12.5.1.1.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 12.5.1.1.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 12.5.1.2.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 12.5.1.2.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Stem Cell Banking Market: By Cell Type, 2020-2030, USD (Million)
        • 12.5.1.3.1. Stem Cell Banking Market: By Bank Type, 2020-2030, USD (Million)
        • 12.5.1.3.1. Stem Cell Banking Market: By Application, 2020-2030, USD (Million)

13. Company Profile

  • 13.1.
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. CBR Systems, Inc.
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Cryo-Cell International, Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Cordlife
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Cryo-Save AG
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Global Cord Blood Corporation
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. Americord Registry LLC
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Smart Cells International Ltd.
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Celgene Corporation
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. BrainStorm Cell Therapeutics
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. Regenerative Medical Services Pvt. Ltd.
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives
  • 13.12. American CryoStem Corporation
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Portfolio
    • 13.12.4. Strategic Initiatives
  • 13.13. Cordlife Group Limited
    • 13.13.1. Company Overview
    • 13.13.2. Financial Performance
    • 13.13.3. Product Portfolio
    • 13.13.4. Strategic Initiatives
  • 13.14. Cryoholdco De LatinoAmerica
    • 13.14.1. Company Overview
    • 13.14.2. Financial Performance
    • 13.14.3. Product Portfolio
    • 13.14.4. Strategic Initiatives
  • 13.15. S.A.P.I. DE C.V.
    • 13.15.1. Company Overview
    • 13.15.2. Financial Performance
    • 13.15.3. Product Portfolio
    • 13.15.4. Strategic Initiatives
  • 13.16. StemCyte Cord Blood Bank
    • 13.16.1. Company Overview
    • 13.16.2. Financial Performance
    • 13.16.3. Product Portfolio
    • 13.16.4. Strategic Initiatives
  • 13.17. Covis Pharma.
    • 13.17.1. Company Overview
    • 13.17.2. Financial Performance
    • 13.17.3. Product Portfolio
    • 13.17.4. Strategic Initiatives
  • 13.18. CSG BIO
    • 13.18.1. Company Overview
    • 13.18.2. Financial Performance
    • 13.18.3. Product Portfolio
    • 13.18.4. Strategic Initiatives
  • 13.19. Others
    • 13.19.1. Company Overview
    • 13.19.2. Financial Performance
    • 13.19.3. Product Portfolio
    • 13.19.4. Strategic Initiatives